Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

35.78CHF
14 Jun 2019
Change (% chg)

-- (--)
Prev Close
CHF35.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
44,559
52-wk High
CHF70.80
52-wk Low
CHF35.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 59.47 -0.815
Jun '18 46.62 -2.074
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 43.90 43.90 43.90 --
Quarter Ending Dec-19 2 67.65 89.30 46.00 --
Year Ending Dec-19 8 132.44 134.90 124.80 133.44
Year Ending Dec-20 8 160.37 187.50 144.90 159.29
Earnings (per share)
Quarter Ending Jun-19 2 -2.57 -2.22 -2.91 --
Quarter Ending Dec-19 2 -1.57 -0.13 -3.00 --
Year Ending Dec-19 8 -2.88 -1.83 -3.80 -0.80
Year Ending Dec-20 8 0.17 2.79 -2.33 2.14
LT Growth Rate (%) 1 -19.20 -19.20 -19.20 --
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.12 37.45
P/E High - Last 5 Yrs. -- 165.13 57.55
P/E Low - Last 5 Yrs. -- 52.03 28.57
Beta 1.18 1.18 0.96
Price to Sales (TTM) 4.01 42.73 10.02
Price to Book (MRQ) -- 12.58 4.53
Price to Tangible Book (MRQ) -- 18.14 5.33
Price to Cash Flow (TTM) -- 68.10 26.07
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.61
Dividend Yield - 5 Year Avg 0.00 0.05 1.35
Dividend 5 Year Growth Rate -- 0.79 6.52
Payout Ratio(TTM) -- 1.51 36.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 20.12 61.11 15.38
Sales (TTM) vs TTM 1 Yr. Ago 17.00 46.83 8.69
Sales - 5 Yr. Growth Rate 20.97 33.28 10.31
EPS (MRQ) vs Qtr. 1 Yr. Ago -835.06 -9.16 18.28
EPS (TTM) vs TTM 1 Yr. Ago -61.59 -- --
EPS - 5 Yr. Growth Rate -- 22.24 7.10
Capital Spending - 5 Yr. Growth Rate -12.78 24.81 7.93

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.90 2.77 2.47
Current Ratio (MRQ) 4.12 3.76 3.43
LT Debt to Equity (MRQ) -- 7.55 14.00
Total Debt to Equity (MRQ) -- 20.84 19.69
Interest Coverage (TTM) -2.56 34.79 15.40

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 80.87 26.88 50.06
Gross Margin - 5 Yr. Avg. -- 59.71 51.22
EBITD Margin (TTM) -21.01 -- --
EBITD - 5 Yr. Avg -49.76 -8.97 16.15
Operating Margin (TTM) -22.71 -107.66 -7.35
Operating Margin - 5 Yr. Avg. -52.91 -25.48 11.44
Pre-Tax Margin (TTM) -29.37 -108.99 -7.82
Pre-Tax Margin - 5 Yr. Avg. -57.36 -31.01 16.14
Net Profit Margin (TTM) -29.55 -114.67 -11.61
Net Profit Margin - 5 Yr. Avg. -57.63 -36.34 11.33
Effective Tax Rate (TTM) -- 17.29 20.12
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 471,520 8,835,841 786,836,669
Net Income/Employee (TTM) -139,342 1,777,667 92,111,001
Receivable Turnover (TTM) 24.36 11.54 5.85
Inventory Turnover (TTM) 1.37 2.42 3.71
Asset Turnover (TTM) 0.34 0.33 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.91 6.33 9.71
Return on Assets - 5 Yr. Avg. -12.62 6.22 10.70
Return on Investment (TTM) -12.88 7.69 12.16
Return on Investment - 5 Yr. Avg. -16.04 8.15 13.61
Return on Equity (TTM) -- 8.19 16.93
Return on Equity - 5 Yr. Avg. -- 9.23 15.13
  1 Year 3 Year 5 Year
Sales % 17.00 27.11 20.97
EPS (TTM) % -62.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -15.33 -16.95 99 53
13 Week -26.32 -29.05 99 48
26 Week -19.49 -28.76 99 36
52 Week -49.14 -55.11 99 12
YTD -10.46 -23.36 99 11
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.82%
# of Holders: 61
Total Shares Held: 3,780,410
3 Mo. Net Change: -32,632
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 14
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.